Cetrorelix Acetate Kit
Product Images NDC 68083-600

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Cetrorelix Acetate (NDC 68083-600). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cetrorelix-spl-fig.1 (1)

Cetrorelix-spl-fig.1 (1)
An instructional illustration depicting hand washing. One hand is rubbed by the other with water droplets above, indicating a washing action, typically to demonstrate proper hygiene technique.*
FDA Label Image

10 (10)

10 (10)
Instructional diagram showing the preparation and administration steps for cetrorelix acetate kit. The left panel illustrates locating an injection site on the lower abdomen. The right panel depicts a hand holding and preparing a syringe for injection, indicating proper handling before use.*
FDA Label Image

Cetrorelix-spl-fig.11 (11)

Cetrorelix-spl-fig.11 (11)
An instructional illustration showing a hand disposing an object into a container labeled 'BIOHAZARD.' This image relates to proper disposal of biohazardous material, possibly for safe handling in a pharmaceutical or medical context.*
FDA Label Image

Cetrorelix-spl-fig.2 (2)

Cetrorelix-spl-fig.2 (2)
Cetrorelix acetate kit comprising a vial with powder, a syringe with a needle, an ampule or vial with liquid diluent, and an accessory such as a needle or syringe adaptor. Packaged items are intended for reconstitution before administration. Labeler is Gland Pharma Limited.*
FDA Label Image

Cetrorelix-spl-fig.3 (3)

Cetrorelix-spl-fig.3 (3)
An instructional diagram showing two steps for handling a vial. The first step illustrates removing the vial cap by pulling it upward. The second step shows the removal of the stopper from the vial using fingers.*
FDA Label Image

Cetrorelix-spl-fig.4 (4)

Cetrorelix-spl-fig.4 (4)
An instructional illustration showing a syringe with an arrow indicating the removal or attachment of the needle cap. This image is likely part of usage instructions for the cetrorelix acetate kit by Gland Pharma Limited.*
FDA Label Image

Cetrorelix-spl-fig.5 (5)

Cetrorelix-spl-fig.5 (5)
An instructional illustration showing the preparation of a dose by drawing liquid from a vial into a syringe, with an arrow indicating the flow direction. This image is likely part of the cetrorelix acetate kit usage instructions.*
FDA Label Image

Cetrorelix-spl-fig.6 (6)

Cetrorelix-spl-fig.6 (6)
Instructional illustration showing hands preparing an injection by drawing liquid from a vial into a syringe, related to cetrorelix acetate kit by Gland Pharma Limited.*
FDA Label Image

Cetrorelix-spl-fig.7 (7)

Cetrorelix-spl-fig.7 (7)
An instructional illustration showing a step in the assembly or preparation of a syringe with a vial. It depicts a vial positioned above a syringe with an arrow indicating downward movement, likely demonstrating the process of drawing medication into the syringe.*
FDA Label Image

Cetrorelix-spl-fig.8 (8)

Cetrorelix-spl-fig.8 (8)
An instructional diagram showing how to assemble a syringe kit. The illustration depicts removing a cap from a vial, attaching the needle to the syringe, and preparing the injector for use, corresponding to the cetrorelix acetate kit.*
FDA Label Image

Cetrorelix-spl-fig.9 (9)

Cetrorelix-spl-fig.9 (9)
An instructional illustration showing a syringe and needle with an arrow indicating the removal of a cap or cover from the needle, typically demonstrating a step in medication preparation or administration.*
FDA Label Image

Cetrorelix-spl-pfs-label (Pfs Label)

Cetrorelix-spl-pfs-label (Pfs Label)
Label for 1 mL Prefilled Sterile Water for Injection, USP, manufactured by Gland Pharma Limited. The label includes the NDC 68083-599-01, barcode, lot number, and expiration date fields. It is marked Rx only and designed for sterile water injection use.*
FDA Label Image

Cetrorelix-spl-principle-carton (Principle Carton)

Cetrorelix-spl-principle-carton (Principle Carton)
Packaging label for Cetrorelix Acetate for Injection 0.25 mg/vial kit by Gland Pharma Limited. The carton contains a single-dose vial with lyophilized powder, one pre-filled syringe with diluent, and two needles (20-gauge and 27-gauge). The product is for subcutaneous use and is sterile. Storage instructions indicate refrigeration at 2-8°C (36-46°F).*
FDA Label Image

Cetrorelix-spl-structure (Structure)

Cetrorelix-spl-structure (Structure)
Chemical structure diagram of cetrorelix acetate depicting the specific arrangement of atoms and bonds in this peptide-based active ingredient.*
FDA Label Image

Cetrorelix-spl-tray-label (Tray Label)

Cetrorelix-spl-tray-label (Tray Label)
The label for Cetrorelix Acetate for Injection 0.25 mg/vial kit from Gland Pharma Limited, which includes one single-dose vial with lyophilized powder, a pre-filled syringe with diluent, a 20-gauge needle, and a 27-gauge needle. The label states storage instructions to refrigerate at 2-8°C and specifies the product is sterile for subcutaneous use only.*
FDA Label Image

Cetrorelix-spl-vial-label (Vial Label)

Cetrorelix-spl-vial-label (Vial Label)
Label for Cetrorelix Acetate for Injection 0.25 mg per single-dose vial by Gland Pharma Limited. The sterile vial is for subcutaneous use only and should be stored refrigerated at 2-8°C (36-46°F) protected from light. The label includes storage instructions, manufacturer details, and a barcode with NDC 68083-598.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.